ARKG vs ARKK
ARK Genomic Revolution ETF vs ARK Innovation ETF
ARKG$43.17
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
ARKK$81.73
ARK Innovation ETF
Active disruptive-innovation strategy.
Expense: 0.75%Yield: 0.00%
Side-by-side metrics
| Metric | ARKG | ARKK |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.75% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.00% |
AUM Assets under management — bigger funds are typically more liquid. | $1.73B | $6.53B |
YTD return | 44.53% | 4.21% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.38 | 2.46 |
P/E ratio | — | 48.18 |
Last price | $43.17 | $81.73 |
Inception | — | — |
Issuer | ARK | ARK |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 9.15% |
| TEM | Tempus AI Inc Class A common stock | 7.64% |
| ABSI | Absci Corp | 7.01% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 7.00% |
| CRSP | CRISPR Therapeutics AG | 6.56% |
| PSNL | Personalis Inc | 6.19% |
| BEAM | Beam Therapeutics Inc | 4.34% |
| GH | Guardant Health Inc | 4.28% |
| NTRA | Natera Inc | 4.11% |
| ILMN | Illumina Inc | 3.98% |
Sector breakdown · ARKG
Healthcare100.0%
ARKK top holdings
Top holdings · ARKK
| TSLA | Tesla Inc | 10.19% |
| TEM | Tempus AI Inc Class A common stock | 5.58% |
| AMD | Advanced Micro Devices Inc | 4.98% |
| CRSP | CRISPR Therapeutics AG | 4.87% |
| HOOD | Robinhood Markets Inc Class A | 4.49% |
| SPCX | Space Exploration Technologies Corp Class A | 4.48% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 4.18% |
| TWST | Twist Bioscience Corp | 3.95% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 3.53% |
| BEAM | Beam Therapeutics Inc | 3.31% |
Sector breakdown · ARKK
Consumer Cyclical13.0%
Technology25.8%
Communication Services7.1%
Financial Services12.8%
Industrials9.3%
Healthcare32.0%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About ARKK
ARKK (ARK Innovation ETF) is Active disruptive-innovation strategy. Managed by ARK, the fund carries $6.5B in assets under management, an expense ratio of 0.75%. Its largest holding is Tesla Inc (TSLA), which represents 10.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 13.0%.